开能健康(300272.SZ)拟设立细胞行业全资子公司 打造第二增长曲线

Group 1 - The company plans to establish a wholly-owned subsidiary in Hainan or Hunan provinces to engage in the cell industry and related mergers and acquisitions [1] - The registered capital for the new subsidiary will be 100 million yuan [1] - This move aims to strengthen the company's positioning in the cell industry and create a second growth curve for the company [1]